Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/0BO stock hub

FRA/0BO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/0BOis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
43.8B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/0BO
In the news

Latest news · FRA/0BO

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E35.3
P25 n/aP50 n/aP75 n/a
Trailing P/E42.9
P25 n/aP50 n/aP75 n/a
ROE14.5
P25 n/aP50 n/aP75 n/a
ROIC34.4
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/0BO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
196
Groups with data
11
Currency
CNY
Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
China
Country code
DE
Employees
20,602
Employees Change
364%
Employees Change Percent
1.8
Enterprise value
EUR 38.8B
Exchange
Frankfurt Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 43.8B
Price
EUR 6.9
Price currency
EUR
Rev Per Employee
198,754.62x
Sic
2834
Symbol
fra/0BO
Website
https://www.hengrui.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
2.33%
EV Earnings
37.98x
EV/EBIT
35.96x
EV/EBITDA
32.69x
EV/FCF
36.27x
EV/Sales
9.53x
FCF yield
2.44%
Forward P/E
35.29x
P/B ratio
5.43x
P/E ratio
42.88x
P/S ratio
10.69x
PE Ratio10 Y
61.6x
PE Ratio3 Y
56.68x
PE Ratio5 Y
59.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
26.5%
EBITDA Margin
29.03%
FCF margin
26.11%
Gross margin
86.27%
Gross Profit
EUR 3.5B
Gross Profit Growth
11.54%
Gross Profit Growth Q
14.87%
Gross Profit Growth3 Y
16.47%
Gross Profit Growth5 Y
1.87%
Net Income
EUR 1B
Net Income Growth
18.67%
Net Income Growth Q
21.78%
Net Income Growth3 Y
27.6%
Net Income Growth5 Y
4.52%
Pretax Margin
28.22%
Profit Margin
24.93%
Profit Per Employee
EUR 49,555
ROA
8.8
Roa5y
6.83
ROCE
13.14
ROE
14.54
Roe5y
12.69
ROIC
34.38
Roic5y
23.81

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
FCF Growth
84.3%
FCF Growth5 Y
45.81%
OCF Growth
70.55%
OCF Growth Q
41.66%
OCF Growth10 Y
16.72%
OCF Growth3 Y
104.99%
OCF Growth5 Y
40.59%
Revenue Growth
11.55x
Revenue Growth Q
12.98x
Revenue Growth3 Y
15.22x
Revenue Growth5 Y
2.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.53
Assets
EUR 9B
Cash
EUR 5.1B
Current Assets
EUR 6.5B
Current Liabilities
EUR 702.8M
Debt
EUR 8.5M
Debt EBITDA
EUR 0.01
Debt Equity
EUR 0
Debt FCF
EUR 0.01
Equity
EUR 8.1B
Interest Coverage
2,228.3
Liabilities
EUR 898.7M
Long Term Assets
EUR 2.5B
Long Term Liabilities
EUR 195.8M
Net Cash
EUR 5.1B
Net Cash By Market Cap
EUR 11.65
Net Cash Growth
68.42%
Net Debt EBITDA
EUR -4.29
Net Debt Equity
EUR -0.63
Net Debt FCF
EUR -4.77
Tangible Book Value
EUR 7.7B
Tangible Book Value Per Share
EUR 1.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
9.23
Inventory Turnover
1.69
Net Working Capital
EUR 729.6M
Quick ratio
8.36
Working Capital
EUR 5.8B
Working Capital Turnover
EUR 0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

8
MetricValue
Dividend Growth
0%
Dividend Growth Years
0%
Dividend per share
EUR 0.02
Dividend Years
1
Dividend Yield
0.36%
Ex Div Date
2026-04-29
Last Dividend
EUR 0.02
Payout Ratio
15.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

31
MetricValue
200-day SMA
7.98
50-day SMA
7.08
50-day SMA vs 200-day SMA
50under200
All Time High
10.4
All Time High Change
-33.65%
All Time High Date
2025-10-08
All Time Low
5.72
All Time Low Change
20.63%
All Time Low Date
2025-07-01
ATR
0.18
Ch YTD
-9.8
High
6.9
High52
10.4
High52 Date
2025-10-08
High52ch
-33.65%
Low
6.85
Low52
5.72
Low52 Date
2025-07-01
Low52ch
20.63%
Ma50ch
-2.6%
Price vs 200-day SMA
-13.48%
RSI
43.44
RSI Monthly
0
RSI Weekly
44.15
Sharpe ratio
0.34x
Sortino ratio
0.73
Total Return
0.36%
Tr YTD
-9.48
Tr1m
-4.49%
Tr1w
-4.83%
Tr3m
-3.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 1.1B
Operating Income Growth
22.87
Operating Income Growth Q
26.86
Operating Income Growth3 Y
41.71
Operating Income Growth5 Y
5.99
Operating margin
26.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

4
MetricValue
Float
3,722,932,709%
Net Borrowing
-6,071,524.3
Shares Insiders
0.12%
Shares Institutions
28.41%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

52
MetricValue
Adjusted FCF
EUR 1.1B
Average Volume
0x
Bv Per Share
1.19
CAPEX
EUR -372.8M
Ch1m
-4.83
Ch1w
-4.83
Ch3m
-4.17
Ch6m
-9.8
Change
-1.43%
Change From Open
0.73
Close
7
Days Gap
-2.14
Depreciation Amortization
102,545,277.7
Earnings Date
2026-08-20
EBIT
EUR 1.1B
EBITDA
EUR 1.2B
EPS
EUR 0.15
F Score
4
FCF
EUR 1.1B
FCF EV Yield
2.76x
Financing CF
1,038,266,472
Fiscal Year End
December
Founded
1,970
Graham Number
2.14528
Graham Upside
-68.91
Income Tax
EUR 134.2M
Investing CF
-368,750,352
Is Primary Listing
0
Last Report Date
2026-03-31
Lynch Fair Value
EUR 0.8
Lynch Upside
-88.34
Ma150
7.78
Ma150ch
-11.31%
Ma20
7.16
Ma20ch
-3.56%
Net CF
2,018,385,754
Next Earnings Date
2026-08-20
Open
6.85
P FCF Ratio
40.95
P OCF Ratio
30.36
Payment Date
2026-05-27
Position In Range
100
Ppne
1,013,478,214.9
Price Date
2026-05-08
Price EBITDA
EUR 36.83
Ptbv Ratio
5.67
Revenue
4,094,742,733x
Tax By Revenue
3.28x
Tax Rate
11.62%
Tr6m
-9.48%
Volume
0
Z Score
35.34
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

FRA/0BO dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.4%
$0.02 annual per share
Payout ratio
+15.8%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
n/a
0 consecutive years of growth
Total shareholder yield
+0.4%
Next ex-dividend date: 2026-04-29
Ownership

Who owns FRA/0BO?

Insider, institutional, and short-interest positioning.

Institutional ownership
+28.4%
Share of float held by funds and institutions
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

FRA/0BO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
43.4
Neutral momentum band
Price vs 200-day MA
-13.5%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.34
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/0BO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/0BO stock rating?

fra/0BO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/0BO analysis?

The full report lives at /stocks/fra/0BO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/0BO?

The latest report frames fra/0BO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/0BO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/0BO stock profile: metrics, valuation and analysis | Agente AI del Mercato Azionario